TSPAN32 and precursor B-cell acute lymphoblastic leukemia: Importantly, our results indicate that TSPAN32 downregulation is not restricted to T-ALL, as reduced expression was also observed in B-ALL and chronic lymphocytic leukemia (CLL), highlighting a broader pattern of suppression that transcends specific lymphoid lineages.